Allocating CBO’s Estimates of Federal Medicaid Spending Reductions and Enrollment Loss Across the States

The Congressional Budget Office’s (CBO) latest cost estimate shows that the One Big Beautiful Bill would reduce federal Medicaid spending by $723 billion, with an estimated Medicaid enrollment loss of 10.3 million people in 2034. Building on prior KFF analysis, this analysis allocates these estimated federal spending reductions and enrollment losses across the states.

Read More

Workplace Violence Prevention in 2025

Workplace violence prevention is an ongoing and organic process. Federal and state regulations change frequently, so employers may consider regularly reviewing and updating their prevention plans and training programs on a scheduled timeline. The post Workplace Violence Prevention in 2025 appeared first on MedCity News.

Read More

Precision Pfizer Drug Leads to ‘Unprecedented’ Survival in Colorectal Cancer, Data at ASCO Show

Pfizer drug Braftovi achieved statistically significant and clinically meaningful improvement in overall survival for colorectal cancer patients in a Phase 3 clinical trial. The results will be presented Friday during the annual meeting of the American Society of Clinical Oncology. The post Precision Pfizer Drug Leads to ‘Unprecedented’ Survival in Colorectal Cancer, Data at ASCO…

Read More

Opioid Settlement Windfall: Where the Billions Are Going

LISTEN: Tens of thousands of people have filed claims for compensation from pharmaceutical companies accused of fueling the opioid crisis. But few have actually gotten a check. On May 28, WAMU’s “Health Hub” featured KFF Health News senior correspondent Aneri Pattani, who explained why some survivors feel like the money isn’t going to the right…

Read More

Biden’s cancer diagnosis should be a teaching moment

By DANIEL STONE Joe Biden’s metastatic cancer diagnosis brings together two controversial issues: PSA testing for prostate cancer and presidential politics. To understand what is at stake Americans need basic information about PSA testing, and a frank discussion of the reasoning behind the prostate cancer screening decisions in the former president’s case. The dribble of…

Read More